[5 years' data are convincing. Lopinavir as primary therapy is effective and safe in the long term].
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D048588:Benzoxazines; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D003521:Cyclopropanes; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008134:Long-Term Care; D061466:Lopinavir; D063065:Organophosphonates / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use; D011744:Pyrimidinones / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use; D000068698:Tenofovir; D019562:Viral Load
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D017320:HIV Protease Inhibitors; D063065:Organophosphonates; D010078:Oxazines; D011744:Pyrimidinones; D061466:Lopinavir; D000068698:Tenofovir; D000225:Adenine; C098320:efavirenz; D019438:Ritonavir
5-Jahres-Daten überzeugend. Lopinavir in der Primärtherapie dauerhaft und sicher wirksam.